This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Life Sciences
Alta Life Sciences was born of the desire to unite Altamar Capital Partners with an extraordinary team with great life sciences company investment experience, led by Guy Nohra and aided by Montserrat Vendrell, Miguel Valls and Scott Moonly. The objective is to turn this into one of the most important life science investment vehicles in Spain. The new team is based in Barcelona.
Its first fund, Alta Life Sciences Spain I, is characterized by investing in companies across a range of growth and development phases. It will cover all areas, including biotechnology, medical devices, diagnostics, genomes and digital health.
Alta Life Sciences aims to become a bridge between the two sides of the Atlantic, aiming to unite Spain’s scientific ecosystem with Silicon Valley experience. Alta will invest in companies based in Spain or foreign firms that want to be based in Spain. There are several reasons that make our country an ideal place to invest in this sector.
The Alta team summarizes them in four points:
Numerous high level research and development centers
Excellent hospital infrastructure
Numerous life sciences companies
The competitive advantage derived from having lower research and development costs than the U.S., but with similar talent.
Funds under management
| PROGRAM | VINTAGE | INVESTMENT STRATEGY | MARKET SEGMENT | LINK |
|---|---|---|---|---|
| Alta Life Sciences Spain I FCR | 2016 | Investments in Biotechnology, Biopharma, Medical Devices / Diagnostics, Genomics and Digital Health | All development stages: Seed, Series A, Series B y Series C,D,E… | More |
